Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience

OBJECTIVES: The outcomes of refractory and relapsed acute myeloid leukemia (AML) patients in developing countries are underreported, even though the similar classic regimens are widely used. METHODS: We conducted a retrospective comparison of “MEC” (mitoxantrone, etoposide, and cytarabine) and “FLAG...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva, Wellington Fernandes, da Rosa, Lidiane Inês, Seguro, Fernanda Salles, Silveira, Douglas Rafaele Almeida, Bendit, Israel, Buccheri, Valeria, Velloso, Elvira Deolinda Rodrigues Pereira, Rocha, Vanderson, Rego, Eduardo M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade de Medicina / USP 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134553/
https://www.ncbi.nlm.nih.gov/pubmed/32294670
http://dx.doi.org/10.6061/clinics/2020/e1566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134553/
https://www.ncbi.nlm.nih.gov/pubmed/32294670
http://dx.doi.org/10.6061/clinics/2020/e1566

Ejemplares similares